Corrigendum to “DiaBetter Together: Clinical trial protocol for a strengths-based Peer Mentor intervention for young adults with type 1 diabetes transitioning to adult care” [Contemporary Clinical Trials Volume 147, December 2024, 107713].
Samantha A. Carreon , Charles G. Minard , Sarah K. Lyons , Wendy Levy , Stephanie Camey , Kishan Desai , Brenda Duran , Randi Streisand , Barbara J. Anderson , Siripoom V. McKay , Tricia S. Tang , Sridevi Devaraj , Ryan Ramphul , Marisa E. Hilliard
{"title":"Corrigendum to “DiaBetter Together: Clinical trial protocol for a strengths-based Peer Mentor intervention for young adults with type 1 diabetes transitioning to adult care” [Contemporary Clinical Trials Volume 147, December 2024, 107713].","authors":"Samantha A. Carreon , Charles G. Minard , Sarah K. Lyons , Wendy Levy , Stephanie Camey , Kishan Desai , Brenda Duran , Randi Streisand , Barbara J. Anderson , Siripoom V. McKay , Tricia S. Tang , Sridevi Devaraj , Ryan Ramphul , Marisa E. Hilliard","doi":"10.1016/j.cct.2025.107977","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10636,"journal":{"name":"Contemporary clinical trials","volume":"155 ","pages":"Article 107977"},"PeriodicalIF":2.0000,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contemporary clinical trials","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1551714425001715","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
期刊介绍:
Contemporary Clinical Trials is an international peer reviewed journal that publishes manuscripts pertaining to all aspects of clinical trials, including, but not limited to, design, conduct, analysis, regulation and ethics. Manuscripts submitted should appeal to a readership drawn from disciplines including medicine, biostatistics, epidemiology, computer science, management science, behavioural science, pharmaceutical science, and bioethics. Full-length papers and short communications not exceeding 1,500 words, as well as systemic reviews of clinical trials and methodologies will be published. Perspectives/commentaries on current issues and the impact of clinical trials on the practice of medicine and health policy are also welcome.